img

Global Molecular Imaging Agents Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Molecular Imaging Agents Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Molecular imaging is a new biomedical research discipline which enables the quantification, visualization, and characterization of biologic processes taking place at the cellular and subcellular levels. Molecular imaging plays a very important role in diagnosis of early assessment, risk stratification, and follow-up of patients with neurological diseases. Imaging agents are the substances designed to improve the imaging output of specific organs, physiological functions, tissues and diseases. Molecular imaging agents are small molecules, peptides, engineered proteins, aptamers and nanoparticles. The main purpose of a molecular imaging agent is to cross-examine and report back about a specific target of interest during the course of a molecular imaging study.
The global Molecular Imaging Agents market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
Based on types, the global molecular imaging agents market is segmented into small molecules, peptides, engineered protein fragments, aptamers, nanoparticles and others. Amongst all, peptides have emerged as a very important type of molecular imaging agents. Based on application, the global molecular imaging agents market is segmented into oncology, cardiology, gastrointestinal disorders and neurology disoeder. Similarly, based on end user, the market is segmented into, hospitals and clinics, ambulatory surgical centers, diagnostic & imaging centers, and others. Diagnostic & imaging centers are expected to hold maximum share in the market due to the ease of availability of medication.
In terms of sales (consumption) side, this report focuses on the sales of Molecular Imaging Agents by regions (Countries), company, by type and by type. from 2018 to 2023 and forecast to 2034.
The global Molecular Imaging Agents market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Molecular Imaging Agents market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


General Electric
Bracco Diagnostic
Eisai
Guerbet
By Type
Small Molecules
Peptides
Engineered Protein Fragments
Aptamers
Nanoparticles
Others
By Application
Oncology
Cardiology
Gastrointestinal Disorders
Neurology Disorders
Others
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Molecular Imaging Agents in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Molecular Imaging Agents manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Molecular Imaging Agents sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Molecular Imaging Agents Definition
1.2 Market by Type
1.2.1 Global Molecular Imaging Agents Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Small Molecules
1.2.3 Peptides
1.2.4 Engineered Protein Fragments
1.2.5 Aptamers
1.2.6 Nanoparticles
1.2.7 Others
1.3 Market Segment by Application
1.3.1 Global Molecular Imaging Agents Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Gastrointestinal Disorders
1.3.5 Neurology Disorders
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Molecular Imaging Agents Sales
2.1 Global Molecular Imaging Agents Revenue Estimates and Forecasts 2018-2034
2.2 Global Molecular Imaging Agents Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Molecular Imaging Agents Revenue by Region
2.3.1 Global Molecular Imaging Agents Revenue by Region (2018-2023)
2.3.2 Global Molecular Imaging Agents Revenue by Region (2024-2034)
2.4 Global Molecular Imaging Agents Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Molecular Imaging Agents Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Molecular Imaging Agents Sales Quantity by Region
2.6.1 Global Molecular Imaging Agents Sales Quantity by Region (2018-2023)
2.6.2 Global Molecular Imaging Agents Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Molecular Imaging Agents Sales Quantity by Manufacturers
3.1.1 Global Molecular Imaging Agents Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Molecular Imaging Agents Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Molecular Imaging Agents Sales in 2024
3.2 Global Molecular Imaging Agents Revenue by Manufacturers
3.2.1 Global Molecular Imaging Agents Revenue by Manufacturers (2018-2023)
3.2.2 Global Molecular Imaging Agents Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Molecular Imaging Agents Revenue in 2024
3.3 Global Molecular Imaging Agents Sales Price by Manufacturers
3.4 Global Key Players of Molecular Imaging Agents, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Molecular Imaging Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Molecular Imaging Agents, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Molecular Imaging Agents, Product Offered and Application
3.8 Global Key Manufacturers of Molecular Imaging Agents, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Molecular Imaging Agents Sales Quantity by Type
4.1.1 Global Molecular Imaging Agents Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Molecular Imaging Agents Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Molecular Imaging Agents Sales Quantity Market Share by Type (2018-2034)
4.2 Global Molecular Imaging Agents Revenue by Type
4.2.1 Global Molecular Imaging Agents Historical Revenue by Type (2018-2023)
4.2.2 Global Molecular Imaging Agents Forecasted Revenue by Type (2024-2034)
4.2.3 Global Molecular Imaging Agents Revenue Market Share by Type (2018-2034)
4.3 Global Molecular Imaging Agents Price by Type
4.3.1 Global Molecular Imaging Agents Price by Type (2018-2023)
4.3.2 Global Molecular Imaging Agents Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Molecular Imaging Agents Sales Quantity by Application
5.1.1 Global Molecular Imaging Agents Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Molecular Imaging Agents Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Molecular Imaging Agents Sales Quantity Market Share by Application (2018-2034)
5.2 Global Molecular Imaging Agents Revenue by Application
5.2.1 Global Molecular Imaging Agents Historical Revenue by Application (2018-2023)
5.2.2 Global Molecular Imaging Agents Forecasted Revenue by Application (2024-2034)
5.2.3 Global Molecular Imaging Agents Revenue Market Share by Application (2018-2034)
5.3 Global Molecular Imaging Agents Price by Application
5.3.1 Global Molecular Imaging Agents Price by Application (2018-2023)
5.3.2 Global Molecular Imaging Agents Price Forecast by Application (2024-2034)
6 North America
6.1 North America Molecular Imaging Agents Sales by Company
6.1.1 North America Molecular Imaging Agents Revenue by Company (2018-2023)
6.1.2 North America Molecular Imaging Agents Sales Quantity by Company (2018-2023)
6.2 North America Molecular Imaging Agents Market Size by Type
6.2.1 North America Molecular Imaging Agents Sales Quantity by Type (2018-2034)
6.2.2 North America Molecular Imaging Agents Revenue by Type (2018-2034)
6.3 North America Molecular Imaging Agents Market Size by Application
6.3.1 North America Molecular Imaging Agents Sales Quantity by Application (2018-2034)
6.3.2 North America Molecular Imaging Agents Revenue by Application (2018-2034)
6.4 North America Molecular Imaging Agents Market Size by Country
6.4.1 North America Molecular Imaging Agents Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Molecular Imaging Agents Revenue by Country (2018-2034)
6.4.3 North America Molecular Imaging Agents Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Molecular Imaging Agents Sales by Company
7.1.1 Europe Molecular Imaging Agents Sales Quantity by Company (2018-2023)
7.1.2 Europe Molecular Imaging Agents Revenue by Company (2018-2023)
7.2 Europe Molecular Imaging Agents Market Size by Type
7.2.1 Europe Molecular Imaging Agents Sales Quantity by Type (2018-2034)
7.2.2 Europe Molecular Imaging Agents Revenue by Type (2018-2034)
7.3 Europe Molecular Imaging Agents Market Size by Application
7.3.1 Europe Molecular Imaging Agents Sales Quantity by Application (2018-2034)
7.3.2 Europe Molecular Imaging Agents Revenue by Application (2018-2034)
7.4 Europe Molecular Imaging Agents Market Size by Country
7.4.1 Europe Molecular Imaging Agents Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Molecular Imaging Agents Revenue by Country (2018-2034)
7.4.3 Europe Molecular Imaging Agents Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Molecular Imaging Agents Sales by Company
8.1.1 China Molecular Imaging Agents Sales Quantity by Company (2018-2023)
8.1.2 China Molecular Imaging Agents Revenue by Company (2018-2023)
8.2 China Molecular Imaging Agents Market Size by Type
8.2.1 China Molecular Imaging Agents Sales Quantity by Type (2018-2034)
8.2.2 China Molecular Imaging Agents Revenue by Type (2018-2034)
8.3 China Molecular Imaging Agents Market Size by Application
8.3.1 China Molecular Imaging Agents Sales Quantity by Application (2018-2034)
8.3.2 China Molecular Imaging Agents Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Molecular Imaging Agents Sales by Company
9.1.1 APAC Molecular Imaging Agents Sales Quantity by Company (2018-2023)
9.1.2 APAC Molecular Imaging Agents Revenue by Company (2018-2023)
9.2 APAC Molecular Imaging Agents Market Size by Type
9.2.1 APAC Molecular Imaging Agents Sales Quantity by Type (2018-2034)
9.2.2 APAC Molecular Imaging Agents Revenue by Type (2018-2034)
9.3 APAC Molecular Imaging Agents Market Size by Application
9.3.1 APAC Molecular Imaging Agents Sales Quantity by Application (2018-2034)
9.3.2 APAC Molecular Imaging Agents Revenue by Application (2018-2034)
9.4 APAC Molecular Imaging Agents Market Size by Region
9.4.1 APAC Molecular Imaging Agents Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Molecular Imaging Agents Revenue by Region (2018-2034)
9.4.3 APAC Molecular Imaging Agents Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Molecular Imaging Agents Sales by Company
10.1.1 Middle East, Africa and Latin America Molecular Imaging Agents Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Molecular Imaging Agents Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Molecular Imaging Agents Market Size by Type
10.2.1 Middle East, Africa and Latin America Molecular Imaging Agents Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Molecular Imaging Agents Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Molecular Imaging Agents Market Size by Application
10.3.1 Middle East, Africa and Latin America Molecular Imaging Agents Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Molecular Imaging Agents Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Molecular Imaging Agents Market Size by Country
10.4.1 Middle East, Africa and Latin America Molecular Imaging Agents Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Molecular Imaging Agents Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Molecular Imaging Agents Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 General Electric
11.1.1 General Electric Company Information
11.1.2 General Electric Overview
11.1.3 General Electric Molecular Imaging Agents Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 General Electric Molecular Imaging Agents Products and Services
11.1.5 General Electric Molecular Imaging Agents SWOT Analysis
11.1.6 General Electric Recent Developments
11.2 Bracco Diagnostic
11.2.1 Bracco Diagnostic Company Information
11.2.2 Bracco Diagnostic Overview
11.2.3 Bracco Diagnostic Molecular Imaging Agents Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 Bracco Diagnostic Molecular Imaging Agents Products and Services
11.2.5 Bracco Diagnostic Molecular Imaging Agents SWOT Analysis
11.2.6 Bracco Diagnostic Recent Developments
11.3 Eisai
11.3.1 Eisai Company Information
11.3.2 Eisai Overview
11.3.3 Eisai Molecular Imaging Agents Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Eisai Molecular Imaging Agents Products and Services
11.3.5 Eisai Molecular Imaging Agents SWOT Analysis
11.3.6 Eisai Recent Developments
11.4 Guerbet
11.4.1 Guerbet Company Information
11.4.2 Guerbet Overview
11.4.3 Guerbet Molecular Imaging Agents Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Guerbet Molecular Imaging Agents Products and Services
11.4.5 Guerbet Molecular Imaging Agents SWOT Analysis
11.4.6 Guerbet Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Molecular Imaging Agents Value Chain Analysis
12.2 Molecular Imaging Agents Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Molecular Imaging Agents Production Mode & Process
12.4 Molecular Imaging Agents Sales and Marketing
12.4.1 Molecular Imaging Agents Sales Channels
12.4.2 Molecular Imaging Agents Distributors
12.5 Molecular Imaging Agents Customers
13 Market Dynamics
13.1 Molecular Imaging Agents Industry Trends
13.2 Molecular Imaging Agents Market Drivers
13.3 Molecular Imaging Agents Market Challenges
13.4 Molecular Imaging Agents Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Molecular Imaging Agents Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Small Molecules
Table 3. Major Manufacturers of Peptides
Table 4. Major Manufacturers of Engineered Protein Fragments
Table 5. Major Manufacturers of Aptamers
Table 6. Major Manufacturers of Nanoparticles
Table 7. Major Manufacturers of Others
Table 8. Global Molecular Imaging Agents Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 9. Global Molecular Imaging Agents Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Molecular Imaging Agents Revenue by Region (2018-2023) & (US$ Million)
Table 11. Global Molecular Imaging Agents Revenue Market Share by Region (2018-2023)
Table 12. Global Molecular Imaging Agents Revenue by Region (2024-2034) & (US$ Million)
Table 13. Global Molecular Imaging Agents Revenue Market Share by Region (2024-2034)
Table 14. Global Molecular Imaging Agents Sales Quantity by Region: 2018 VS 2024 VS 2034 (K MT)
Table 15. Global Molecular Imaging Agents Sales by Region (2018-2023) & (K MT)
Table 16. Global Molecular Imaging Agents Sales Market Share by Region (2018-2023)
Table 17. Global Molecular Imaging Agents Sales by Region (2024-2034) & (K MT)
Table 18. Global Molecular Imaging Agents Sales Market Share by Region (2024-2034)
Table 19. Global Molecular Imaging Agents Sales Quantity by Manufacturers (2018-2023) & (K MT)
Table 20. Global Molecular Imaging Agents Sales Quantity Share by Manufacturers (2018-2023)
Table 21. Global Molecular Imaging Agents Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 22. Global Molecular Imaging Agents Revenue Share by Manufacturers (2018-2023)
Table 23. Global Molecular Imaging Agents Price by Manufacturers 2018-2023 (USD/MT)
Table 24. Global Key Players of Molecular Imaging Agents, Industry Ranking, 2021 VS 2024
Table 25. Global Molecular Imaging Agents Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global Molecular Imaging Agents by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Molecular Imaging Agents as of 2024)
Table 27. Global Key Manufacturers of Molecular Imaging Agents, Manufacturing Base Distribution and Headquarters
Table 28. Global Key Manufacturers of Molecular Imaging Agents, Product Offered and Application
Table 29. Global Key Manufacturers of Molecular Imaging Agents, Date of Enter into This Industry
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Molecular Imaging Agents Sales Quantity by Type (2018-2023) & (K MT)
Table 32. Global Molecular Imaging Agents Sales Quantity by Type (2024-2034) & (K MT)
Table 33. Global Molecular Imaging Agents Sales Quantity Share by Type (2018-2023)
Table 34. Global Molecular Imaging Agents Sales Quantity Share by Type (2024-2034)
Table 35. Global Molecular Imaging Agents Revenue by Type (2018-2023) & (US$ Million)
Table 36. Global Molecular Imaging Agents Revenue by Type (2024-2034) & (US$ Million)
Table 37. Global Molecular Imaging Agents Revenue Share by Type (2018-2023)
Table 38. Global Molecular Imaging Agents Revenue Share by Type (2024-2034)
Table 39. Molecular Imaging Agents Price by Type (2018-2023) & (USD/MT)
Table 40. Global Molecular Imaging Agents Price Forecast by Type (2024-2034) & (USD/MT)
Table 41. Global Molecular Imaging Agents Sales Quantity by Application (2018-2023) & (K MT)
Table 42. Global Molecular Imaging Agents Sales Quantity by Application (2024-2034) & (K MT)
Table 43. Global Molecular Imaging Agents Sales Quantity Share by Application (2018-2023)
Table 44. Global Molecular Imaging Agents Sales Quantity Share by Application (2024-2034)
Table 45. Global Molecular Imaging Agents Revenue by Application (2018-2023) & (US$ Million)
Table 46. Global Molecular Imaging Agents Revenue by Application (2024-2034) & (US$ Million)
Table 47. Global Molecular Imaging Agents Revenue Share by Application (2018-2023)
Table 48. Global Molecular Imaging Agents Revenue Share by Application (2024-2034)
Table 49. Molecular Imaging Agents Price by Application (2018-2023) & (USD/MT)
Table 50. Global Molecular Imaging Agents Price Forecast by Application (2024-2034) & (USD/MT)
Table 51. North America Molecular Imaging Agents Revenue by Company (2018-2023) & (US$ Million)
Table 52. North America Molecular Imaging Agents Sales Quantity by Company (2018-2023) & (K MT)
Table 53. North America Molecular Imaging Agents Sales Quantity by Type (2018-2023) & (K MT)
Table 54. North America Molecular Imaging Agents Sales Quantity by Type (2024-2034) & (K MT)
Table 55. North America Molecular Imaging Agents Revenue by Type (2018-2023) & (US$ Million)
Table 56. North America Molecular Imaging Agents Revenue by Type (2024-2034) & (US$ Million)
Table 57. North America Molecular Imaging Agents Sales Quantity by Application (2018-2023) & (K MT)
Table 58. North America Molecular Imaging Agents Sales Quantity by Application (2024-2034) & (K MT)
Table 59. North America Molecular Imaging Agents Revenue by Application (2018-2023) & (US$ Million)
Table 60. North America Molecular Imaging Agents Revenue by Application (2024-2034) & (US$ Million)
Table 61. North America Molecular Imaging Agents Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 62. North America Molecular Imaging Agents Revenue by Country (2018-2023) & (US$ Million)
Table 63. North America Molecular Imaging Agents Revenue by Country (2024-2034) & (US$ Million)
Table 64. North America Molecular Imaging Agents Sales Quantity by Country (2018-2023) & (K MT)
Table 65. North America Molecular Imaging Agents Sales Quantity by Country (2024-2034) & (K MT)
Table 66. Europe Molecular Imaging Agents Sales Quantity by Company (2018-2023) & (K MT)
Table 67. Europe Molecular Imaging Agents Revenue by Company (2018-2023) & (US$ Million)
Table 68. Europe Molecular Imaging Agents Sales Quantity by Type (2018-2023) & (K MT)
Table 69. Europe Molecular Imaging Agents Sales Quantity by Type (2024-2034) & (K MT)
Table 70. Europe Molecular Imaging Agents Revenue by Type (2018-2023) & (US$ Million)
Table 71. Europe Molecular Imaging Agents Revenue by Type (2024-2034) & (US$ Million)
Table 72. Europe Molecular Imaging Agents Sales Quantity by Application (2018-2023) & (K MT)
Table 73. Europe Molecular Imaging Agents Sales Quantity by Application (2024-2034) & (K MT)
Table 74. Europe Molecular Imaging Agents Revenue by Application (2018-2023) & (US$ Million)
Table 75. Europe Molecular Imaging Agents Revenue by Application (2024-2034) & (US$ Million)
Table 76. Europe Molecular Imaging Agents Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 77. Europe Molecular Imaging Agents Revenue by Country (2018-2023) & (US$ Million)
Table 78. Europe Molecular Imaging Agents Revenue by Country (2024-2034) & (US$ Million)
Table 79. Europe Molecular Imaging Agents Sales Quantity by Country (2018-2023) & (K MT)
Table 80. Europe Molecular Imaging Agents Sales Quantity by Country (2024-2034) & (K MT)
Table 81. China Molecular Imaging Agents Sales Quantity by Company (2018-2023) & (K MT)
Table 82. China Molecular Imaging Agents Revenue by Company (2018-2023) & (US$ Million)
Table 83. China Molecular Imaging Agents Sales Quantity by Type (2018-2023) & (K MT)
Table 84. China Molecular Imaging Agents Sales Quantity by Type (2024-2034) & (K MT)
Table 85. China Molecular Imaging Agents Revenue by Type (2018-2023) & (US$ Million)
Table 86. China Molecular Imaging Agents Revenue by Type (2024-2034) & (US$ Million)
Table 87. China Molecular Imaging Agents Sales Quantity by Application (2018-2023) & (K MT)
Table 88. China Molecular Imaging Agents Sales Quantity by Application (2024-2034) & (K MT)
Table 89. China Molecular Imaging Agents Revenue by Application (2018-2023) & (US$ Million)
Table 90. China Molecular Imaging Agents Revenue by Application (2024-2034) & (US$ Million)
Table 91. APAC Molecular Imaging Agents Sales Quantity by Company (2018-2023) & (K MT)
Table 92. APAC Molecular Imaging Agents Revenue by Company (2018-2023) & (US$ Million)
Table 93. APAC Molecular Imaging Agents Sales Quantity by Type (2018-2023) & (K MT)
Table 94. APAC Molecular Imaging Agents Sales Quantity by Type (2024-2034) & (K MT)
Table 95. APAC Molecular Imaging Agents Revenue by Type (2018-2023) & (US$ Million)
Table 96. APAC Molecular Imaging Agents Revenue by Type (2024-2034) & (US$ Million)
Table 97. APAC Molecular Imaging Agents Sales Quantity by Application (2018-2023) & (K MT)
Table 98. APAC Molecular Imaging Agents Sales Quantity by Application (2024-2034) & (K MT)
Table 99. APAC Molecular Imaging Agents Revenue by Application (2018-2023) & (US$ Million)
Table 100. APAC Molecular Imaging Agents Revenue by Application (2024-2034) & (US$ Million)
Table 101. APAC Molecular Imaging Agents Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 102. APAC Molecular Imaging Agents Revenue by Region (2018-2023) & (US$ Million)
Table 103. APAC Molecular Imaging Agents Revenue by Region (2024-2034) & (US$ Million)
Table 104. APAC Molecular Imaging Agents Sales Quantity by Region (2018-2023) & (K MT)
Table 105. APAC Molecular Imaging Agents Sales Quantity by Region (2024-2034) & (K MT)
Table 106. Middle East, Africa and Latin America Molecular Imaging Agents Sales Quantity by Company (2018-2023) & (K MT)
Table 107. Middle East, Africa and Latin America Molecular Imaging Agents Revenue by Company (2018-2023) & (US$ Million)
Table 108. Middle East, Africa and Latin America Molecular Imaging Agents Sales Quantity by Type (2018-2023) & (K MT)
Table 109. Middle East, Africa and Latin America Molecular Imaging Agents Sales Quantity by Type (2024-2034) & (K MT)
Table 110. Middle East, Africa and Latin America Molecular Imaging Agents Revenue by Type (2018-2023) & (US$ Million)
Table 111. Middle East, Africa and Latin America Molecular Imaging Agents Revenue by Type (2024-2034) & (US$ Million)
Table 112. Middle East, Africa and Latin America Molecular Imaging Agents Sales Quantity by Application (2018-2023) & (K MT)
Table 113. Middle East, Africa and Latin America Molecular Imaging Agents Sales Quantity by Application (2024-2034) & (K MT)
Table 114. Middle East, Africa and Latin America Molecular Imaging Agents Revenue by Application (2018-2023) & (US$ Million)
Table 115. Middle East, Africa and Latin America Molecular Imaging Agents Revenue by Application (2024-2034) & (US$ Million)
Table 116. Middle East, Africa and Latin America Molecular Imaging Agents Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 117. Middle East, Africa and Latin America Molecular Imaging Agents Revenue by Country (2018-2023) & (US$ Million)
Table 118. Middle East, Africa and Latin America Molecular Imaging Agents Revenue by Country (2024-2034) & (US$ Million)
Table 119. Middle East, Africa and Latin America Molecular Imaging Agents Sales Quantity by Country (2018-2023) & (K MT)
Table 120. Middle East, Africa and Latin America Molecular Imaging Agents Sales Quantity by Country (2024-2034) & (K MT)
Table 121. General Electric Company Information
Table 122. General Electric Description and Overview
Table 123. General Electric Molecular Imaging Agents Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 124. General Electric Molecular Imaging Agents Product and Services
Table 125. General Electric Molecular Imaging Agents SWOT Analysis
Table 126. General Electric Recent Developments
Table 127. Bracco Diagnostic Company Information
Table 128. Bracco Diagnostic Description and Overview
Table 129. Bracco Diagnostic Molecular Imaging Agents Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 130. Bracco Diagnostic Molecular Imaging Agents Product and Services
Table 131. Bracco Diagnostic Molecular Imaging Agents SWOT Analysis
Table 132. Bracco Diagnostic Recent Developments
Table 133. Eisai Company Information
Table 134. Eisai Description and Overview
Table 135. Eisai Molecular Imaging Agents Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 136. Eisai Molecular Imaging Agents Product and Services
Table 137. Eisai Molecular Imaging Agents SWOT Analysis
Table 138. Eisai Recent Developments
Table 139. Guerbet Company Information
Table 140. Guerbet Description and Overview
Table 141. Guerbet Molecular Imaging Agents Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 142. Guerbet Molecular Imaging Agents Product and Services
Table 143. Guerbet Molecular Imaging Agents SWOT Analysis
Table 144. Guerbet Recent Developments
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Molecular Imaging Agents Distributors List
Table 148. Molecular Imaging Agents Customers List
Table 149. Molecular Imaging Agents Market Trends
Table 150. Molecular Imaging Agents Market Drivers
Table 151. Molecular Imaging Agents Market Challenges
Table 152. Molecular Imaging Agents Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Molecular Imaging Agents Product Picture
Figure 2. Global Molecular Imaging Agents Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Molecular Imaging Agents Market Share by Type in 2024 & 2034
Figure 4. Small Molecules Product Picture
Figure 5. Peptides Product Picture
Figure 6. Engineered Protein Fragments Product Picture
Figure 7. Aptamers Product Picture
Figure 8. Nanoparticles Product Picture
Figure 9. Others Product Picture
Figure 10. Global Molecular Imaging Agents Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 11. Global Molecular Imaging Agents Market Share by Application in 2024 & 2034
Figure 12. Oncology
Figure 13. Cardiology
Figure 14. Gastrointestinal Disorders
Figure 15. Neurology Disorders
Figure 16. Others
Figure 17. Molecular Imaging Agents Report Years Considered
Figure 18. Global Molecular Imaging Agents Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 19. Global Molecular Imaging Agents Revenue 2018-2034 (US$ Million)
Figure 20. Global Molecular Imaging Agents Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 21. Global Molecular Imaging Agents Sales Quantity 2018-2034 (K MT)
Figure 22. Global Molecular Imaging Agents Sales Quantity Market Share by Region (2018-2023)
Figure 23. Global Molecular Imaging Agents Sales Quantity Market Share by Region (2024-2034)
Figure 24. North America Molecular Imaging Agents Sales Quantity YoY (2018-2034) & (K MT)
Figure 25. North America Molecular Imaging Agents Revenue YoY (2018-2034) & (US$ Million)
Figure 26. Europe Molecular Imaging Agents Sales Quantity YoY (2018-2034) & (K MT)
Figure 27. Europe Molecular Imaging Agents Revenue YoY (2018-2034) & (US$ Million)
Figure 28. China Molecular Imaging Agents Sales Quantity YoY (2018-2034) & (K MT)
Figure 29. China Molecular Imaging Agents Revenue YoY (2018-2034) & (US$ Million)
Figure 30. APAC Molecular Imaging Agents Sales Quantity YoY (2018-2034) & (K MT)
Figure 31. APAC Molecular Imaging Agents Revenue YoY (2018-2034) & (US$ Million)
Figure 32. Middle East, Africa and Latin America Molecular Imaging Agents Sales Quantity YoY (2018-2034) & (K MT)
Figure 33. Middle East, Africa and Latin America Molecular Imaging Agents Revenue YoY (2018-2034) & (US$ Million)
Figure 34. The Top 10 and Top 5 Players Market Share by Molecular Imaging Agents Sales Quantity in 2024
Figure 35. The Top 10 and Top 5 Players Market Share by Molecular Imaging Agents Revenue in 2024
Figure 36. Molecular Imaging Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 37. Global Molecular Imaging Agents Sales Quantity Market Share by Type (2018-2034)
Figure 38. Global Molecular Imaging Agents Revenue Market Share by Type (2018-2034)
Figure 39. Global Molecular Imaging Agents Sales Quantity Market Share by Application (2018-2034)
Figure 40. Global Molecular Imaging Agents Revenue Market Share by Application (2018-2034)
Figure 41. North America Molecular Imaging Agents Revenue Market Share by Company in 2024
Figure 42. North America Molecular Imaging Agents Sales Quantity Market Share by Company in 2024
Figure 43. North America Molecular Imaging Agents Sales Quantity Market Share by Type (2018-2034)
Figure 44. North America Molecular Imaging Agents Revenue Market Share by Type (2018-2034)
Figure 45. North America Molecular Imaging Agents Sales Quantity Market Share by Application (2018-2034)
Figure 46. North America Molecular Imaging Agents Revenue Market Share by Application (2018-2034)
Figure 47. North America Molecular Imaging Agents Revenue Share by Country (2018-2034)
Figure 48. North America Molecular Imaging Agents Sales Quantity Share by Country (2018-2034)
Figure 49. U.S. Molecular Imaging Agents Revenue (2018-2034) & (US$ Million)
Figure 50. Canada Molecular Imaging Agents Revenue (2018-2034) & (US$ Million)
Figure 51. Europe Molecular Imaging Agents Sales Quantity Market Share by Company in 2024
Figure 52. Europe Molecular Imaging Agents Revenue Market Share by Company in 2024
Figure 53. Europe Molecular Imaging Agents Sales Quantity Market Share by Type (2018-2034)
Figure 54. Europe Molecular Imaging Agents Revenue Market Share by Type (2018-2034)
Figure 55. Europe Molecular Imaging Agents Sales Quantity Market Share by Application (2018-2034)
Figure 56. Europe Molecular Imaging Agents Revenue Market Share by Application (2018-2034)
Figure 57. Europe Molecular Imaging Agents Revenue Share by Country (2018-2034)
Figure 58. Europe Molecular Imaging Agents Sales Quantity Share by Country (2018-2034)
Figure 59. Germany Molecular Imaging Agents Revenue (2018-2034) & (US$ Million)
Figure 60. France Molecular Imaging Agents Revenue (2018-2034) & (US$ Million)
Figure 61. U.K. Molecular Imaging Agents Revenue (2018-2034) & (US$ Million)
Figure 62. Italy Molecular Imaging Agents Revenue (2018-2034) & (US$ Million)
Figure 63. Russia Molecular Imaging Agents Revenue (2018-2034) & (US$ Million)
Figure 64. China Molecular Imaging Agents Sales Quantity Market Share by Company in 2024
Figure 65. China Molecular Imaging Agents Revenue Market Share by Company in 2024
Figure 66. China Molecular Imaging Agents Sales Quantity Market Share by Type (2018-2034)
Figure 67. China Molecular Imaging Agents Revenue Market Share by Type (2018-2034)
Figure 68. China Molecular Imaging Agents Sales Quantity Market Share by Application (2018-2034)
Figure 69. China Molecular Imaging Agents Revenue Market Share by Application (2018-2034)
Figure 70. APAC Molecular Imaging Agents Sales Quantity Market Share by Company in 2024
Figure 71. APAC Molecular Imaging Agents Revenue Market Share by Company in 2024
Figure 72. APAC Molecular Imaging Agents Sales Quantity Market Share by Type (2018-2034)
Figure 73. APAC Molecular Imaging Agents Revenue Market Share by Type (2018-2034)
Figure 74. APAC Molecular Imaging Agents Sales Quantity Market Share by Application (2018-2034)
Figure 75. APAC Molecular Imaging Agents Revenue Market Share by Application (2018-2034)
Figure 76. APAC Molecular Imaging Agents Revenue Share by Region (2018-2034)
Figure 77. APAC Molecular Imaging Agents Sales Quantity Share by Region (2018-2034)
Figure 78. Japan Molecular Imaging Agents Revenue (2018-2034) & (US$ Million)
Figure 79. South Korea Molecular Imaging Agents Revenue (2018-2034) & (US$ Million)
Figure 80. China Taiwan Molecular Imaging Agents Revenue (2018-2034) & (US$ Million)
Figure 81. Southeast Asia Molecular Imaging Agents Revenue (2018-2034) & (US$ Million)
Figure 82. India Molecular Imaging Agents Revenue (2018-2034) & (US$ Million)
Figure 83. Middle East, Africa and Latin America Molecular Imaging Agents Sales Quantity Market Share by Company in 2024
Figure 84. Middle East, Africa and Latin America Molecular Imaging Agents Revenue Market Share by Company in 2024
Figure 85. Middle East, Africa and Latin America Molecular Imaging Agents Sales Quantity Market Share by Type (2018-2034)
Figure 86. Middle East, Africa and Latin America Molecular Imaging Agents Revenue Market Share by Type (2018-2034)
Figure 87. Middle East, Africa and Latin America Molecular Imaging Agents Sales Quantity Market Share by Application (2018-2034)
Figure 88. Middle East, Africa and Latin America Molecular Imaging Agents Revenue Market Share by Application (2018-2034)
Figure 89. Middle East, Africa and Latin America Molecular Imaging Agents Sales Quantity Share by Country (2018-2034)
Figure 90. Middle East, Africa and Latin America Molecular Imaging Agents Revenue Share by Country (2018-2034)
Figure 91. Brazil Molecular Imaging Agents Revenue (2018-2034) & (US$ Million)
Figure 92. Mexico Molecular Imaging Agents Revenue (2018-2034) & (US$ Million)
Figure 93. Turkey Molecular Imaging Agents Revenue (2018-2034) & (US$ Million)
Figure 94. Israel Molecular Imaging Agents Revenue (2018-2034) & (US$ Million)
Figure 95. GCC Countries Molecular Imaging Agents Revenue (2018-2034) & (US$ Million)
Figure 96. Molecular Imaging Agents Value Chain
Figure 97. Molecular Imaging Agents Production Process
Figure 98. Channels of Distribution (Direct Vs Distribution)
Figure 99. Distributors Profiles
Figure 100. Bottom-up and Top-down Approaches for This Report
Figure 101. Data Triangulation
Figure 102. Key Executives Interviewed